Skip to content

Opening book details…

About this Medicine article

Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial by Hortobagyi, Gabriel N. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Hortobagyi, Gabriel N.
Publisher
BioMed Central; Springer (Biomed Central Ltd.); Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1465-5411)
Published
2018
Field
Medicine (Health Sciences)

More by Hortobagyi, Gabriel N.

Browse all works by Hortobagyi, Gabriel N.